# Biorestorative (BRTX) — Earnings

BRTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/brtx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$6.60 |
| EPS estimate | −$7.20 |
| EPS surprise | +8.33% |
| Revenue surprise | −97.43% |
| Revenue | $11,800.00 |
| Revenue estimate | $460,000.00 |
| Reported | Nov 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1505497/000149315225021993/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/077ae9b4-cc10-fca3-1309-7242e6d5bc3b.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 12, 2025 | −$7.20 | −$6.60 | 8.33% | $460,000.00 | $11,800.00 |
| Q2 2025 | Aug 12, 2025 | −$7.40 | −$6.00 | 18.92% | $340,000.00 | $303,000.00 |
| Q1 2025 | May 14, 2025 | −$6.50 | −$12.80 | -96.92% | $380,000.00 | $25,000.00 |
| Q4 2024 | Mar 27, 2025 | −$6.87 | −$4.00 | 41.75% | $483,333.00 | $43,000.00 |
| Q3 2024 | Nov 12, 2024 | −$8.67 | −$2.60 | 70.00% | $333,333.00 | $234,000.00 |
| Q2 2024 | Aug 13, 2024 | −$11.40 | −$10.00 | 12.28% | $10,000.00 | $89,000.00 |
| Q1 2024 | Jun 11, 2024 | −$10.40 | −$6.60 | 36.54% | $15,000.00 | $35,000.00 |
| Q4 2023 | Apr 1, 2024 | −$13.80 | −$12.00 | 13.04% | $30,000.00 | $19,000.00 |
| Q3 2023 | Nov 13, 2023 | −$13.60 | −$12.80 | 5.88% | $30,000.00 | $31,000.00 |
| Q2 2023 | Aug 11, 2023 | −$15.90 | −$15.40 | 3.14% | $65,000.00 | $65,000.00 |
| Q3 2022 | Nov 14, 2022 | −$29.00 | −$25.60 | 11.72% | — | — |
| Q2 2022 | Aug 15, 2022 | −$11.00 | −$25.60 | -132.73% | — | $85,500.00 |
| Q3 2021 | Nov 15, 2021 | −$99.80 | −$99.80 | 0.00% | $8,000.00 | $100,000.00 |

## Frequently Asked Questions

### When did Biorestorative (BRTX) last report earnings?

Biorestorative last reported on Nov 12, 2025, covering fiscal Q3 2025.

### Did BRTX beat earnings estimates?

Yes. Biorestorative reported EPS of −$6.60 for Q3 2025 against a −$7.20 estimate — a 8.33% beat.

### How much revenue did BRTX report last quarter?

Biorestorative reported $11,800.00 in revenue for Q3 2025, against a consensus estimate of $460,000.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).